Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non-Malignant Neoplasm × thymoglobulin × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Non-Malignant Neoplasm 1

Interventions

thymoglobulin 1 fludarabine phosphate 1 fludarabine 1 Whole-Body Irradiation 1 Stem Cell Transplantation 1 Sirolimus 1 Mycophenolic Acid 1 Hematopoietic Stem Cell Transplantation 1 Cyclophosphamide 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting

Non-Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡